At the end of 2022, FDA published a draft guidance on Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers. The draft guidance explains several aspects of the VMSR Program, including FDA’s approach to determining the eligibility of product codes for the program. Consistent with the goals outlined in the Medical Device User Fee Amendments of 2017 (MDUFA IV) Commitment Letter, the VMSR Program streamlines reporting of device malfunctions. The program began in 2018 when FDA issued an order granting an alternative reporting approach under 21 CFR 803.19. The ...
Blog Editors
Recent Updates
- Importance of Negotiating Holdover Provisions in Health Care Leases
- Supreme Court Rejects Challenge to FDA Approval of Mifepristone on Standing, but the Battle Continues
- New State Laws Requiring Notice of Health Care Transactions Will Uniquely Impact Distressed Transactions
- Unpacking Averages: Growth of AI/ML in Medicine as Evidenced by Clinical Trials
- Interested in Opening a Medical Spa? (Part II): Here’s (More) That You Need to Know